SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $9,807,000 | – | 148,250 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 173,845 | $7,037,000 | 0.28% |
| AMUNDI ASSET MANAGEMENT US, INC. | 537,900 | $21,774,000 | 0.09% |
| NOMURA HOLDINGS INC | 127,903 | $5,175,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 386,458 | $15,641,000 | 0.01% |
| AQR Capital Management | 26,000 | $1,052,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 100,000 | $4,047,000 | 0.00% |
| RATIONAL ADVISORS LLC | 288 | $12,000 | 0.00% |
| HSBC HOLDINGS PLC | 5,448 | $220,000 | 0.00% |